Spots Global Cancer Trial Database for prophylaxis
Every month we try and update this database with for prophylaxis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia | NCT01259713 | Invasive Fungal... | Liposomal ampho... Placebo | 18 Years - | Gilead Sciences | |
| Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma | NCT01042704 | Myeloma | Bendamustine Lenalidomide Dexamethasone Aspirin Prophylaxis Antibiotic Biweekly Follow... Cyclical Follow... Restaging Post-Treatment ... | 18 Years - | University of Pittsburgh | |
| Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens | NCT01428973 | Graft-Versus-Ho... Hematological M... | Mycophenolate m... Sirolimus | 16 Years - 75 Years | University of Liege | |
| Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia | NCT01259713 | Invasive Fungal... | Liposomal ampho... Placebo | 18 Years - | Gilead Sciences | |
| Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients | NCT00135876 | Venous Thromboe... Brain Tumors | dalteparin | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER. | NCT01589146 | The Primary Stu... Safety of Exten... Prophylaxis Giv... Surgery for Col... The Clinical Be... the Incidence o... From Surgery in... | Heparin, Low-Mo... | 18 Years - | University Of Perugia | |
| Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis | NCT03428711 | Superficial Ven... | Mesoglycan Oral... Placebo Oral Ta... | 18 Years - 90 Years | Quovadis Associazione | |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | NCT01431326 | Adenovirus Anesthesia Anxiety Anxiolysis Autism Autistic Disord... Bacterial Menin... Bacterial Septi... Benzodiazepine Bipolar Disorde... Bone and Joint ... Central Nervous... Convulsions Cytomegalovirus... Early-onset Sch... Epilepsy General Anesthe... Gynecologic Inf... Herpes Simplex ... Infantile Heman... Infection Inflammation Inflammatory Co... Intra-abdominal... Lower Respirato... Migraines Pain Pneumonia Schizophrenia Sedation Seizures Skeletal Muscle... Skin and Skin-s... Treatment-resis... Urinary Tract I... Withdrawal Sepsis Gram-negative I... Bradycardia Cardiac Arrest Cardiac Arrhyth... Staphylococcal ... Nosocomial Pneu... Neuromuscular B... Methicillin Res... Endocarditis Neutropenia Headache Fibrinolytic Bl... Pulmonary Arter... CMV Retinitis Hypertension Chronic Kidney ... Hyperaldosteron... Hypokalemia Heart Failure Hemophilia Heavy Menstrual... Insomnia | The POPS study ... | - 21 Years | Duke University | |
| Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning | NCT03852407 | Acute Myeloid L... Myelodysplastic... Chronic Myeloid... Myeloproliferat... Myeloproliferat... Acute Lymphoid ... Multiple Myelom... Chronic Lymphoi... Non Hodgkin Lym... Hodgkin Lymphom... | Thymoglobulin Melphalan Fludarabine Cyclophosphamid | 18 Years - 75 Years | University of Liege | |
| Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT | NCT03395860 | Graft-versus-ho... Prophylaxis | ATG | 14 Years - 70 Years | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | |
| Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy | NCT02093910 | Multiple Myelom... | Monosialotetrah... | 18 Years - 80 Years | Sun Yat-sen University | |
| Multi-Center Human Alert Trial to Prevent DVT and PE | NCT00409136 | Pulmonary Embol... Deep Vein Throm... Cancer Surgery | Human Alert | 18 Years - | Brigham and Women's Hospital | |
| Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells | NCT00398411 | Hodgkin Disease Non-Hodgkin Lym... Multiple Myelom... Bacteremia | moxifloxacin placebo | 18 Years - 75 Years | University of Cologne | |
| PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT | NCT04669210 | Graft-versus-ho... Stem Cell Trans... Acute Myeloid L... Acute Lymphoid ... | Ruxolitinib Tacrolimus Mycophenolate M... | 18 Years - 70 Years | St. Petersburg State Pavlov Medical University | |
| Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia | NCT02440178 | Acute Leukemia | Micafungin | 18 Years - 75 Years | Seoul National University Hospital | |
| Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy | NCT00294749 | Men Who Must Un... | Ciprofloxacine | 18 Years - | Poitiers University Hospital | |
| Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia | NCT00936117 | Leukemia Fungal Infectio... | Posaconazole | 18 Years - | M.D. Anderson Cancer Center | |
| Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy | NCT00413439 | Acute Myeloid L... | Isavuconazole | 18 Years - | Basilea Pharmaceutica | |
| Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells | NCT00398411 | Hodgkin Disease Non-Hodgkin Lym... Multiple Myelom... Bacteremia | moxifloxacin placebo | 18 Years - 75 Years | University of Cologne | |
| Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient | NCT02958059 | Biliary Obstruc... Benign Biliary ... Peri-ampullary ... Bile Duct Cance... Klatskin Tumor | Pacetin® (cefox... Placebo | 19 Years - | Yonsei University | |
| Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect | NCT05204758 | Advanced Lung A... | TCM Formula Placebo | 20 Years - | China Medical University Hospital | |
| Intermittent Liposomal Amphotericin B Primary Prophylaxis | NCT00451711 | Acute Myeloid L... | Liposomal ampho... | 18 Years - 80 Years | Bayside Health | |
| Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia | NCT01658956 | Breast Cancer | GCSF administra... | - | Jules Bordet Institute | |
| Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy | NCT00294749 | Men Who Must Un... | Ciprofloxacine | 18 Years - | Poitiers University Hospital | |
| Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB) | NCT04209192 | Urinary Tract I... Bladder Cancer Urologic Surgic... | Fosfomycin Trom... Amikacin | 18 Years - | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | |
| Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect | NCT05204758 | Advanced Lung A... | TCM Formula Placebo | 20 Years - | China Medical University Hospital | |
| Longitudinal Incision Versus Cruciate Incision in the Construction of an End Colostomy | NCT04397783 | Colorectal Neop... Parastomal Hern... Colostomy Stoma | construction of... | 18 Years - 85 Years | Hospital Donostia | |
| Multi-Center Human Alert Trial to Prevent DVT and PE | NCT00409136 | Pulmonary Embol... Deep Vein Throm... Cancer Surgery | Human Alert | 18 Years - | Brigham and Women's Hospital | |
| TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer | NCT05625932 | Colorectal Canc... Thromboembolism | Tinzaparin | 18 Years - | Galician Research Group on Digestive Tumors | |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | NCT01431326 | Adenovirus Anesthesia Anxiety Anxiolysis Autism Autistic Disord... Bacterial Menin... Bacterial Septi... Benzodiazepine Bipolar Disorde... Bone and Joint ... Central Nervous... Convulsions Cytomegalovirus... Early-onset Sch... Epilepsy General Anesthe... Gynecologic Inf... Herpes Simplex ... Infantile Heman... Infection Inflammation Inflammatory Co... Intra-abdominal... Lower Respirato... Migraines Pain Pneumonia Schizophrenia Sedation Seizures Skeletal Muscle... Skin and Skin-s... Treatment-resis... Urinary Tract I... Withdrawal Sepsis Gram-negative I... Bradycardia Cardiac Arrest Cardiac Arrhyth... Staphylococcal ... Nosocomial Pneu... Neuromuscular B... Methicillin Res... Endocarditis Neutropenia Headache Fibrinolytic Bl... Pulmonary Arter... CMV Retinitis Hypertension Chronic Kidney ... Hyperaldosteron... Hypokalemia Heart Failure Hemophilia Heavy Menstrual... Insomnia | The POPS study ... | - 21 Years | Duke University | |
| Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy | NCT02081469 | Hepatitis B, Ch... Tumor | TDF | 18 Years - 70 Years | Chang Gung Memorial Hospital | |
| Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT) | NCT00311896 | Cancer Thrombosis | Bemiparin Placebo | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis | NCT06308445 | Familial Adenom... | Rapamycin | 12 Years - 17 Years | University Hospital, Toulouse | |
| Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine | NCT01580202 | Malignancy Hepatitis B | Entecavir Lamivudine | 18 Years - | Seoul National University Hospital | |
| Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy | NCT00413439 | Acute Myeloid L... | Isavuconazole | 18 Years - | Basilea Pharmaceutica | |
| A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A Children | NCT02999308 | Haemophilia | Observe the pat... | 1 Year - 7 Years | Beijing Children's Hospital | |
| Prophylaxis of Fungal Invasive Infections in Leukemia | NCT00501098 | Invasive Pulmon... | Caspofungin | 18 Years - | Northern Italy Leukemia Group | |
| Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis | NCT03428711 | Superficial Ven... | Mesoglycan Oral... Placebo Oral Ta... | 18 Years - 90 Years | Quovadis Associazione | |
| Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT) | NCT00311896 | Cancer Thrombosis | Bemiparin Placebo | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
